Schubert EA

ORCID: 0000-0002-2533-0001 · 2 papers in corpus

observational 2023

Medicinal cannabis for Australian patients with chronic refractory pain including arthritis

British journal of pain ·doi:10.1177/20494637221147115

OBJECTIVES: To examine the tolerability and effectiveness of medicinal cannabis prescribed to patients for chronic, refractory pain, with a subset analysis on arthritis. METHODS: This was an interim analysis of the CA Clinics Observational…

observational 2023

The Effectiveness and Adverse Events of Cannabidiol and Tetrahydrocannabinol Used in the Treatment of Anxiety Disorders in a PTSD Subpopulation: An Interim Analysis of an Observational Study

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians ·doi:10.1177/87551225231180796

Background: Anxiety is a condition for which current treatments are often limited by adverse events (AEs). Components of medicinal cannabis, cannabidiol (CBD) and tetrahydrocannabinol (THC), have been proposed as potential treatments for an…